Olaparib and Durvalumab in Patients with DNA Damage Repair Alterations and Biochemically Recurrent Prostate Cancer by Karen A. Autio, Deaglan J. McHugh, Dana E. Rathkopf, Han Xiao, Swathi Merugu, Phillip Wong, Mehrin Jan, Tanya B. Dorff, Elisabeth I. Heath, Howard I. Scher

Get full text

Author Correction: Patient perceptions of empathy in physician and artificial intelligence chatbot responses to patient questions about cancer by David Chen, Kabir Chauhan, Rod Parsa, Zhihui Amy Liu, Fei-Fei Liu, Ernie Mak, Lawson Eng, Breffni Louise Hannon, Jennifer Croke, Andrew Hope, Nazanin Fallah-Rad, Phillip Wong, Srinivas Raman

Get full text

Patient perceptions of empathy in physician and artificial intelligence chatbot responses to patient questions about cancer by David Chen, Kabir Chauhan, Rod Parsa, Zhihui Amy Liu, Fei-Fei Liu, Ernie Mak, Lawson Eng, Breffni Louise Hannon, Jennifer Croke, Andrew Hope, Nazanin Fallah-Rad, Phillip Wong, Srinivas Raman

Get full text

Combining a WT1 Vaccine (Galinpepimut-S) With Checkpoint Inhibition (Nivolumab) in Patients With WT1–Expressing Diffuse Pleural Mesothelioma: A Phase 1 Study by Prashasti Agrawal, MD, Michael Offin, MD, Victoria Lai, MD, Michelle S. Ginsberg, MD, Prasad S. Adusumilli, MD, FACS, Valerie W. Rusch, MD, Jennifer L. Sauter, MD, Teresa Ho, BS, Phillip Wong, PhD, Marjorie G. Zauderer, MD

Get full text

Phase II study of rucaparib and nivolumab in patients with leiomyosarcoma by Robert G Maki, Martina Bradic, Phillip Wong, William Tap, Vicky Makker, Sandra D’Angelo, Angela Green, Mrinal M Gounder, Evan Rosenbaum, Ciara M Kelly, Jason E Chan, Ping Chi, Mark A Dickson, Mary L Keohan, Sujana Movva, Viswatej Avutu, Martee L Hensley, Maria M Rubinstein, Ronak Shah, Kenneth Seier, Karmelina Charalambous, Seth M Cohen, Lauren B Banks, Sara Saunds, Jae-Mun Cho, Robert A Lefkowitz, Joseph Erinjeri, Li-Xuan Qin

Get full text